Medical research

How a patient partnership is propelling cancer research

In the fall of 2018, cancer researcher Corrie Painter began presenting some intriguing early results from a new study on a rare and deadly cancer known as angiosarcoma. She and her fellow scientists hoped that by sharing ...

Medications

ALS drug gets rare second review at high-stakes FDA meeting

A closely watched experimental drug for Lou Gehrig's disease got an unusual second look from U.S. regulators on Wednesday, following intense pressure to approve the treatment for those with the fatal illness.

Medications

FDA still skeptical of ALS drug ahead of high-stakes meeting

Federal health regulators remain unconvinced about the benefits of a closely watched experimental drug for the debilitating illness known as Lou Gehrig's disease, even as they prepare to give its drugmaker a rare second opportunity ...

Health

North Dakota abortion clinic prepares for likely final day

North Dakota's only abortion clinic is preparing for what could be its final day of performing procedures, with a trigger ban due to take effect Thursday that will likely force patients to travel hundreds of miles to receive ...

Autism spectrum disorders

Untapped potential: Embracing neurodiversity in medicine

Family physician Jennifer Vassel used to think she was weird. Situations affected her differently than her colleagues. She could remember exact pages from her Grade 6 textbooks. And she had always been highly sensitive to ...

Medications

Stakes are high ahead of FDA panel vote on ALS drug

Advocacy groups are pressing U.S. federal regulators to fast-track approval of an experimental drug treatment for the deadly neurological disease ALS (amyotrophic lateral sclerosis), with a decision expected this week.

page 1 from 11